Chong Kun Dang Pharmaceutical

This was a first-in-human study to see how a new drug called CKD-846 moves through the body and how safe it is. It involved 31 healthy male volunteers. The goal was to gather basic safety and dosing information to see if the drug should be studied further in men with enlarged pro…

This was the first study in humans for an experimental drug called CKD-508. It tested the safety and how the body processes the drug in 44 healthy adults. The main goal was to see if the drug was safe and to measure its levels in the blood, while also checking for early signs of …

This early-stage study aims to understand how an experimental heart drug called CKD-508 interacts with two common medications (midazolam and rosuvastatin) in the body. It involved 24 healthy adult male volunteers to measure drug levels and check for safety. The goal is to gather …

This early-stage study tested how the body absorbs and processes a new combination pill for type 2 diabetes, called CKD-383, compared to taking its three separate drug components. The study involved 30 healthy adult volunteers who took each treatment once, with a week break in be…

This early-stage study aimed to understand how the body processes and tolerates a new combination pill for type 2 diabetes, called CKD-383. Researchers compared it to taking its three separate drug components together. The study involved 31 healthy adult volunteers to measure dru…

This early-stage study aimed to understand how the body processes a new combination diabetes medication (CKD-383) compared to taking its three separate components together. The study involved 30 healthy adult volunteers who received both treatments in a specific order with a brea…